STRO
Sutro BiopharmaNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$448.14M
P/E Ratio
—
EPS
$-23.72
Beta
1.31
52W High
$27.81
52W Low
$5.23
50-Day MA
$19.95
200-Day MA
$11.95
Dividend Yield
—
Profit Margin
-186.50%
Forward P/E
8.96
PEG Ratio
—
About Sutro Biopharma
Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $102.48M |
| Gross Profit (TTM) | $-63.93M |
| EBITDA | $-97.63M |
| Operating Margin | -289.00% |
| Return on Equity | -1810.00% |
| Return on Assets | -23.40% |
| Revenue/Share (TTM) | $12.06 |
| Book Value | $-15.43 |
| Price-to-Book | 2.11 |
| Price-to-Sales (TTM) | 4.37 |
| EV/Revenue | 2.607 |
| EV/EBITDA | 41.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -21.40% |
| Shares Outstanding | $16.57M |
| Float | $15.15M |
| % Insiders | 2.46% |
| % Institutions | 39.97% |
Historical Volatility
HV 10-Day
60.01%
HV 20-Day
68.17%
HV 30-Day
71.57%
HV 60-Day
86.96%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($29.12 target)
1
Strong Buy6
Buy1
Hold1
Strong SellData last updated: 4/9/2026